Evidence map›Paper›PMID 28581198›Full record

ArticlePigment cell & melanoma research2017

FBXW7 inactivation in a Braf

Iraz T Aydin, Franco Abbate, Geena Susan Rajan, Brateil Badal, Iannis Aifantis, Garrett Desman, Julide Tok Celebi

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Pigment cell & melanoma research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Molecular insights and clinical implications for the tumor suppressor role of SCFBiochimica et biophysica acta. Reviews on cancer · 2024
    Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Iraz T AydinDepartment of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Franco AbbateDepartment of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Geena Susan RajanDepartment of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Brateil BadalDepartment of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Iannis AifantisDepartment of Pathology, New York University, New York, NY, USA.
Garrett DesmanDepartment of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Julide Tok CelebiDepartment of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID 0000-0001-9926-3780
Icahn School of Medicine at Mount Sinai · USNew York University · USTisch Hospital · US

Funding

NOTCH inhibition in melanomaR21CA177940 · NCI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI CELEBI, JULIDE T. · 2014 to 2015
$406k
Dissecting the Melanoma GenomeR21CA158557 · NCI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI CELEBI, JULIDE T. · 2012 to 2013
$367k
NCI NIH HHS R21 CA158557NCI NIH HHS R21 CA177940
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Disease Models, AnimalMutationAnimalsF-Box-WD Repeat-Containing Protein 7HumansMelanoma, ExperimentalMiceProto-Oncogene Proteins B-rafBraf protein, mouseF-Box-WD Repeat-Containing Protein 7Fbxw7 protein, mouseProto-Oncogene Proteins B-raf

Identifiers

PMID28581198
PMCPMC5668175
OpenAlexW2623671184

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.